GeneProof, a molecular diagnostics manufacturer and part of NuvinkaDx, announced several significant product and regulatory milestones. The GeneProof Cytomegalovirus (CMV) MC PCR Kit is now available ...

A non-cash impairment charge of approximately $18.9 million related to in-process R&D intangible assets significantly ...

When Domain Associates led Xagenic Inc.’s recent $20 million Series B, it marked the eighth diagnostics investment the firm had made with its $500 million eighth fund. The partners say they’ve ...

Q4 2025 Management View CEO Joshua Riggs announced the submission of GraftAssureDx to the FDA, emphasizing, “we are, to our knowledge, the first dd-cfDNA assay to be submitted to the FDA for ...

5,000-participant, multi-center registry supported by iMDx’s central lab and transplant center partners New hospital-based data seeks to further differentiate pending kitted assay that measures ...

In the following sections, we highlight ethical concerns about early adoption of molecular diagnostic testing without solid evidence or guidelines and offer practical guidance for ethical ...

Join us for an insightful webinar on the critical role of molecular diagnostic testing for respiratory viruses during flu season. This session will explore the importance of accurate and timely ...

Antimicrobial resistance (AMR) represents one of the most pressing global health challenges of the 21st century, threatening the effectiveness of treatments and burdening healthcare systems worldwide.

Neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and other related disorders, represent a ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) ('Plus” or the 'Company”), a healthcare company developing and commercializing ...

Combining traditional dermatopathology with PCR-based molecular testing improves diagnostic accuracy in differentiating ...